{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T04:16:46Z","timestamp":1768882606778,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["UG3\/UH3MD018358"],"award-info":[{"award-number":["UG3\/UH3MD018358"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["U54MD007601"],"award-info":[{"award-number":["U54MD007601"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12185-025-04135-5","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T18:12:49Z","timestamp":1765563169000},"page":"32-40","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epidemiological survey of potential familial myelodysplastic syndromes\/acute myeloid leukemia in Hawaii"],"prefix":"10.1007","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4385-6883","authenticated-orcid":false,"given":"Kensuke","family":"Takaoka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manasawee","family":"Tanariyakul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshito","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic","family":"Chow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Sumida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"issue":"2","key":"4135_CR1","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/j.1365-2141.2012.09136.x","volume":"158","author":"H Holme","year":"2012","unstructured":"Holme H, Hossain U, Kirwan M, Walne A, Vulliamy T, Dokal I. Marked genetic heterogeneity in familial myelodysplasia\/acute myeloid leukaemia. Br J Haematol. 2012;158(2):242\u20138.","journal-title":"Br J Haematol"},{"issue":"10","key":"4135_CR2","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/ng.913","volume":"43","author":"CN Hahn","year":"2011","unstructured":"Hahn CN, Chong C-E, Carmichael CL, Wilkins EJ, Brautigan PJ, Li X-C, et al. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet. 2011;43(10):1012\u20137.","journal-title":"Nat Genet"},{"issue":"4","key":"4135_CR3","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1001\/jamaoncol.2019.5140","volume":"6","author":"E Atallah","year":"2020","unstructured":"Atallah E, Logan B, Chen M, Cutler C, Deeg J, Jacoby M, et al. Comparison of patient age groups in transplantation for myelodysplastic syndrome: the medicare coverage with evidence development study. JAMA Oncol. 2020;6(4):486\u201393.","journal-title":"JAMA Oncol"},{"issue":"18","key":"4135_CR4","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1182\/blood-2014-04-522136","volume":"124","author":"R Bejar","year":"2014","unstructured":"Bejar R, Steensma DP. Recent developments in myelodysplastic syndromes. Blood. 2014;124(18):2793\u2013803.","journal-title":"Blood"},{"issue":"12","key":"4135_CR5","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1056\/NEJMoa1106968","volume":"366","author":"MJ Walter","year":"2012","unstructured":"Walter MJ, Shen D, Ding L, Shao J, Koboldt DC, Chen K, et al. Clonal architecture of secondary acute myeloid leukemia. N Engl J Med. 2012;366(12):1090\u20138.","journal-title":"N Engl J Med"},{"issue":"7","key":"4135_CR6","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1080\/10428194.2020.1734595","volume":"61","author":"K Takaoka","year":"2020","unstructured":"Takaoka K, Koya J, Yoshimi A, Toya T, Kobayashi T, Nannya Y, et al. Nationwide epidemiological survey of familial myelodysplastic syndromes\/acute myeloid leukemia in Japan: a multicenter retrospective study. Leuk Lymphoma. 2020;61(7):1688\u201394.","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"4135_CR7","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1080\/10428194.2022.2032034","volume":"63","author":"SY Goksu","year":"2022","unstructured":"Goksu SY, Ozer M, Goksu BB, Wang R, Khatib J, Patel PA, et al. The impact of race and ethnicity on outcomes of patients with myelodysplastic syndromes: a population-based analysis. Leuk Lymphoma. 2022;63(7):1651\u20139.","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"4135_CR8","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41568-020-00315-z","volume":"21","author":"JM Klco","year":"2021","unstructured":"Klco JM, Mullighan CG. Advances in germline predisposition to acute leukaemias and myeloid neoplasms. Nat Rev Cancer. 2021;21(2):122\u201337.","journal-title":"Nat Rev Cancer"},{"issue":"S1","key":"4135_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.5045\/br.2021.2020327","volume":"56","author":"M Park","year":"2021","unstructured":"Park M. Myelodysplastic syndrome with genetic predisposition. Blood Res. 2021;56(S1):34\u20138.","journal-title":"Blood Res"},{"issue":"1","key":"4135_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/nyas.12346","volume":"1310","author":"AH West","year":"2014","unstructured":"West AH, Godley LA, Churpek JE. Familial myelodysplastic syndrome\/acute leukemia syndromes: a review and utility for translational investigations. Ann NY Acad Sci. 2014;1310(1):111\u20138.","journal-title":"Ann NY Acad Sci"},{"issue":"7","key":"4135_CR11","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1038\/s41375-019-0385-0","volume":"33","author":"K Takaoka","year":"2019","unstructured":"Takaoka K, Kawazu M, Koya J, Yoshimi A, Masamoto Y, Maki H, et al. A germline HLTF mutation in familial MDS induces DNA damage accumulation through impaired PCNA polyubiquitination. Leukemia. 2019;33(7):1773\u201382.","journal-title":"Leukemia"},{"issue":"10","key":"4135_CR12","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.3324\/haematol.2011.043422","volume":"96","author":"E Liew","year":"2011","unstructured":"Liew E, Owen C. Familial myelodysplastic syndromes: a review of the literature. Haematologica. 2011;96(10):1536.","journal-title":"Haematologica"},{"issue":"2","key":"4135_CR13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1365-2141.2007.06909.x","volume":"140","author":"C Owen","year":"2008","unstructured":"Owen C, Barnett M, Fitzgibbon J. Familial myelodysplasia and acute myeloid leukaemia\u2013a review. Br J Haematol. 2008;140(2):123\u201332.","journal-title":"Br J Haematol"},{"issue":"6","key":"4135_CR14","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","volume":"89","author":"P Greenberg","year":"1997","unstructured":"Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89(6):2079\u201388.","journal-title":"Blood"},{"issue":"7","key":"4135_CR15","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2200008","volume":"1","author":"E Bernard","year":"2022","unstructured":"Bernard E, Tuechler H, Greenberg PL, Hasserjian RP, Arango Ossa JE, Nannya Y, et al. Molecular international prognostic scoring system for myelodysplastic syndromes. NEJM Evid. 2022;1(7):EVIDoa2200008.","journal-title":"NEJM Evid"},{"issue":"12","key":"4135_CR16","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","volume":"120","author":"PL Greenberg","year":"2012","unstructured":"Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Sol\u00e9 F, et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012;120(12):2454\u201365.","journal-title":"Blood"},{"issue":"10","key":"4135_CR17","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1182\/blood-2018-06-857102","volume":"133","author":"U Platzbecker","year":"2019","unstructured":"Platzbecker U, Fenaux P, Ad\u00e8s L, Giagounidis A, Santini V, Van De Loosdrecht A, et al. Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials. Blood. 2019;133(10):1020\u201330.","journal-title":"Blood"},{"issue":"2","key":"4135_CR18","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1182\/blood-2005-10-4149","volume":"108","author":"BD Cheson","year":"2006","unstructured":"Cheson BD, Greenberg PL, Bennett JM, Lowenberg B, Wijermans PW, Nimer SD, et al. Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia. Blood. 2006;108(2):419\u201325.","journal-title":"Blood"},{"issue":"17","key":"4135_CR19","first-page":"2047","volume":"141","author":"AM Zeidan","year":"2023","unstructured":"Zeidan AM, Platzbecker U, Bewersdorf JP, Stahl M, Ad\u00e8s L, Borate U, et al. Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromes. Blood J Am Soc Hematol. 2023;141(17):2047\u201361.","journal-title":"Blood J Am Soc Hematol"},{"issue":"12","key":"4135_CR20","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1182\/blood-2014-10-607341","volume":"125","author":"MR Savona","year":"2015","unstructured":"Savona MR, Malcovati L, Komrokji R, Tiu RV, Mughal TI, Orazi A, et al. An international consortium proposal of uniform response criteria for myelodysplastic\/myeloproliferative neoplasms (MDS\/MPN) in adults. Blood. 2015;125(12):1857\u201365.","journal-title":"Blood"},{"issue":"12","key":"4135_CR21","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H D\u00f6hner","year":"2022","unstructured":"D\u00f6hner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140(12):1345\u201377.","journal-title":"Blood"},{"key":"4135_CR22","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.64793","volume":"10","author":"Q Feng","year":"2021","unstructured":"Feng Q, Nickels E, Muskens IS, de Smith AJ, Gauderman WJ, Yee AC, et al. Increased burden of familial-associated early-onset cancer risk among minority Americans compared to non-Latino Whites. Elife. 2021;10:e64793.","journal-title":"Elife"},{"issue":"8","key":"4135_CR23","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/s41436-021-01139-4","volume":"23","author":"C Rehder","year":"2021","unstructured":"Rehder C, Bean LJ, Bick D, Chao E, Chung W, Das S, et al. Next-generation sequencing for constitutional variants in the clinical laboratory, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021;23(8):1399\u2013415.","journal-title":"Genet Med"},{"issue":"4","key":"4135_CR24","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/s41375-021-01425-9","volume":"36","author":"C R\u00e9cher","year":"2022","unstructured":"R\u00e9cher C, R\u00f6llig C, B\u00e9rard E, Bertoli S, Dumas P-Y, Tavitian S, et al. Long-term survival after intensive chemotherapy or hypomethylating agents in AML patients aged 70 years and older: a large patient data set study from European registries. Leukemia. 2022;36(4):913\u201322.","journal-title":"Leukemia"},{"key":"4135_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40364-018-0121-3","volume":"6","author":"K Seiter","year":"2018","unstructured":"Seiter K, Htun K, Baskind P, Liu Z. Acute myeloid leukemia in a father and son with a germline mutation of ASXL1. Biomark Res. 2018;6:1\u20133.","journal-title":"Biomark Res"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-04135-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-025-04135-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-04135-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T15:03:25Z","timestamp":1768835005000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-025-04135-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["4135"],"URL":"https:\/\/doi.org\/10.1007\/s12185-025-04135-5","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"10 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}